Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-004807)

Filing Details

Accession Number:: 0001209191-20-004807
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-24 16:10:12
Reporting Period:: 2020-01-22

Accepted Time:: 2020-01-24 16:10:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1654151	Deciphera Pharmaceuticals Inc.	DCPH	Pharmaceutical Preparations (2834)	200299725

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752827	C. Daniel Martin	C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-01-22	26,999	$36.10	43,999	No	4	M	Direct
Common Stock	Disposition	2020-01-22	26,999	$67.18	17,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-01-22	26,999	$0.00	26,999	$36.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
63,001		2028-09-17	No	4	C	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the shares vested on September 18, 2019 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to continued service through such dates.